Studies & study sites - Malaria & Critical illness
The Malaria & Critical Illness Department has a vibrant and productive network of collaborative study sites throughout South-East Asia, South Asia and Africa, with around 15 studies currently operating in a total of an equal number of countries.
In 2018 the Malaria & Critical illness Department completed the large multi-centre multi-country TRAC II study. This study continued tracking drug-resistant malaria and tested the safely and efficacy of triple ACTs (TACTs) to treat multi-drug resistant falciparum malaria, which is a major and worsening threat to global malaria control and elimination efforts. DeTACT, a large follow-up project funded by DFID will expand the evaluation of TACTs to African countries and aims to have 2 different TACTs ready for deployment by the end of the project.